We propose that targeting Jag-1 in tumour angiogenesis might therefore be an interesting approach and targeting more specifically the Notch3-Jag-1 interaction could be advantageous allowing targeting of both the canonical Notch signalling in epithelial cells and Notch3-induced apoptosis in endothelial cells. This evidence concerns the gene JAG1 and neoplasm.